Additional Information

Description

Enoxaparin PFS 40mg/0.4mL is a low-molecular-weight heparin (LMWH) indicated for the prevention and treatment of thromboembolic disorders. It is commonly used to prevent deep vein thrombosis (DVT) in patients undergoing surgery or experiencing limited mobility. The medication is also utilized in the management of acute coronary syndromes, including unstable angina and myocardial infarction.

The active ingredient, enoxaparin sodium, exerts its anticoagulant effects by inhibiting Factor Xa and thrombin in the coagulation cascade. This selective inhibition prevents the formation of fibrin clots. Its predictable pharmacokinetic profile eliminates the need for routine laboratory monitoring in most cases, simplifying its use in clinical practice.

Enoxaparin PFS is provided in a prefilled syringe containing 40mg of the drug in 0.4mL of solution, ensuring accurate dosing and convenient administration.Common side effects include mild bruising, redness, or irritation at the injection site. Rare but serious adverse events, such as bleeding or thrombocytopenia, require immediate medical attention.